Acumen Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 2.7
| ABOS Stock | USD 2.36 0.05 2.16% |
Acumen |
Acumen Pharmaceuticals Target Price Odds to finish below 2.7
The tendency of Acumen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 2.70 after 90 days |
| 2.36 | 90 days | 2.70 | about 62.92 |
Based on a normal probability distribution, the odds of Acumen Pharmaceuticals to stay under $ 2.70 after 90 days from now is about 62.92 (This Acumen Pharmaceuticals probability density function shows the probability of Acumen Stock to fall within a particular range of prices over 90 days) . Probability of Acumen Pharmaceuticals price to stay between its current price of $ 2.36 and $ 2.70 at the end of the 90-day period is about 45.33 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.97 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Acumen Pharmaceuticals will likely underperform. Additionally Acumen Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Acumen Pharmaceuticals Price Density |
| Price |
Predictive Modules for Acumen Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acumen Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Acumen Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Acumen Pharmaceuticals is not an exception. The market had few large corrections towards the Acumen Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Acumen Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Acumen Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.51 | |
β | Beta against Dow Jones | 2.97 | |
σ | Overall volatility | 0.27 | |
Ir | Information ratio | -0.07 |
Acumen Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acumen Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acumen Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Acumen Pharmaceuticals generated a negative expected return over the last 90 days | |
| Acumen Pharmaceuticals has high historical volatility and very poor performance | |
| Acumen Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.37 M) with loss before overhead, payroll, taxes, and interest of (32.36 M). | |
| Acumen Pharmaceuticals currently holds about 189.91 M in cash with (43.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 78.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Acumen Pharmaceuticals Posts Earnings Results, Misses Estimates By 0.14 EPS |
Acumen Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acumen Stock often depends not only on the future outlook of the current and potential Acumen Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acumen Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.6 M | |
| Cash And Short Term Investments | 243.5 M |
Acumen Pharmaceuticals Technical Analysis
Acumen Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Acumen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acumen Pharmaceuticals. In general, you should focus on analyzing Acumen Stock price patterns and their correlations with different microeconomic environments and drivers.
Acumen Pharmaceuticals Predictive Forecast Models
Acumen Pharmaceuticals' time-series forecasting models is one of many Acumen Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acumen Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Acumen Pharmaceuticals
Checking the ongoing alerts about Acumen Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acumen Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Acumen Pharmaceuticals generated a negative expected return over the last 90 days | |
| Acumen Pharmaceuticals has high historical volatility and very poor performance | |
| Acumen Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.37 M) with loss before overhead, payroll, taxes, and interest of (32.36 M). | |
| Acumen Pharmaceuticals currently holds about 189.91 M in cash with (43.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 78.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Acumen Pharmaceuticals Posts Earnings Results, Misses Estimates By 0.14 EPS |
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.